Ilir Mujalovic

概要

Ilir Mujalovic is the Americas Capital Markets Team Leader and a Lead Industry Coordinator for Healthcare. He is also a member of the Firm’s Policy Committee.

Ilir is a leading capital markets lawyer representing issuers and investment banks on a wide variety of matters, including initial public offerings, follow-on offerings, PIPEs, ATMs, SPACs, de-SPACs, convertible bonds, investment grade notes, high yield debt offerings and other public and private transactions. Ilir works with clients across many industries, including Healthcare, Consumer/Retail, Media and Telecommunications, Industrials, Power and Utilities, Renewables and Financial Institutions among others. Ilir has developed a stellar reputation representing clients on numerous biotech, med-tech, diagnostics and healthcare services transactions.

Ilir also represents corporate clients such as Valvoline Inc. in connection with corporate governance and SEC compliance matters and works with leading investment banks including BofA Securities, Morgan Stanley, Citi, Goldman Sachs, JP Morgan, TD Cowen, Barclays, Deutsche Bank, Jefferies, Piper Sandler, Leerink and UBS.

He is ranked as a leading capital markets lawyer in Chambers & Partners USA 2023 and in prior years and in Legal 500 USA 2023 for his work on initial public offerings, life sciences, healthcare and SPAC offerings.

According to Chambers & Partners, Ilir gets excellent feedback for his representation of issuers and underwriters with impressed clients noting:

“He makes the work look effortless. He's a pleasure to work with, and he's very proactive and efficient. I love working with him.”
“Ilir is at the cutting edge of the market. He has great client service skills, is always available and really knows the market.”
“He is a fantastic attorney. He is very commercial while still ensuring his client’s legal interests are protected and focusing on the detail.”
“He is capable, commercial and he understands the product on a sophisticated level.”
“He is super diligent and highly responsive, and when a diligence issue arises during the deal, everyone has the comfort of knowing that he is on the deal, as he looks out for his client and does not cave into pressures.”
Clients commend “the quality of his work, level of commitment and thoughtfulness” and attest to his “great presence in the room when leading discussions,” reporting him to be “very communicative, engaged and someone who cares about clients and the transactions.”
“His hands-on approach and focus is truly remarkable and he’s my go-to lawyer when it comes to equity issuances.”
“He has an unbelievable work ethic, with a hands-on and pragmatic approach. He is laser-focused on getting to the right outcomes for anything that he works on.”

Client feedback in Legal 500 USA 2023 includes:

“Ilir is by far one of the best lawyers I have and continue to work with. Spent many hours on the phone and zoom with him on a wide variety of equity topics, and especially through the Covid era where SPACs were pricing, and we worked on various PIPEs, Ilir was there to help throughout the course of the process and provide guidance on the more complicated issues.”
“Ilir is an outstanding lawyer, who I have had the chance to work in multiple transactions over the last decade. He’s extremely thoughtful, thorough and hands on and has great business judgment. Ilir is always very focused on delivering the best outcome for clients and is fully on top of every single work stream in a project. He’s extremely experienced and seasoned, but still willing to work very hard and get involved in all important aspects of the deal.”

Ilir is a contributing editor of the book entitled Initial Public Offerings 2022, which provides CEOs, CFOs, investment bankers, general counsel, lawyers and the investing community with a detailed overview of the crucial steps, legal issues and market practices involved in an IPO process in major global markets.

He also recently co-authored a chapter in a book titled Health Care Mergers and Acquisitions Answer Book, published by the Practising Law Institute.

From August 2010 through February 2014, Ilir was a Director and Assistant General Counsel at Bank of America Merrill Lynch where he advised on a broad range of equity and high yield capital markets transactions.

経験

Equity Offerings

BofA Securities and Evercore as placement agents in connection with the private placement by Mineralys Therapeutics, Inc. of 8,339,169 shares of its common stock and pre-funded warrants to purchase 549,755 shares of common stock, resulting in aggregate gross proceeds to Mineralys of approximately $120 million
Deutsche Bank AG, as the PIPE placement agent to Lotus Technology Inc. (Lotus Tech), and Santander US Capital Markets LLC, as the capital markets advisor to L Catterton Asia Acquisition Corp. (LCAA), in connection with the business combination between Lotus Tech and LCAA. The business combination values Lotus Tech at $5.5 billion on a pre-money equity value basis
BofA Securities as placement agent in connection with the commencement of iRobot Corporation’s at-the-market equity program to sell shares of its common stock, no par value, having an aggregate offering price of up to $100 million
Evercore ISI as sales agent in connection with the commencement of Quantum-Si Incorporated’s at-the-market equity program to sell shares of its Class A common stock, having an aggregate offering price of up to $75 million
Morgan Stanley & Co. LLC and Cowen and Company, LLC as joint book-running managers in connection with the follow-on public offering by Vicarious Surgical Inc. of 45,000,000 shares of its common stock at a public offering price of $1.00 per share, resulting in aggregate gross proceeds to Vicarious Surgical Inc. of approximately $45 million
BofA Securities, TD Cowen and Piper Sandler as joint book-running managers in connection with the follow-on public offering by PROCEPT BioRobotics® Corporation of 5,085,494 shares of its common stock at a public offering price of $33.92 per share, resulting in aggregate gross proceeds to by PROCEPT BioRobotics® Corporation of approximately $172.5 million
BofA Securities, Leerink Partners, Evercore ISI and RBC Capital Markets as joint book-running managers in connection with the follow-on public offering by Caribou Biosciences, Inc. of 22,115,384 shares of its common stock at a public offering price of $6.50 per share, resulting in aggregate gross proceeds to Caribou Biosciences, Inc. of approximately $143.75 million
BofA Securities, TD Cowen and Piper Sandler as joint book-running managers in connection with the follow-on public offering by Inozyme Pharma, Inc. of 14,375,000 shares of its common stock at a public offering price of $4.80 per share, resulting in aggregate gross proceeds to Inozyme Pharma, Inc. of approximately $64.5 million
BofA Securities and ThinkEquity LLC as placement agents in connection with the at-the-market offering by Annovis Bio, Inc.
Worldwide Webb Acquisition Corp in connection with its acquisition of Aeries Technology
Cowen and Company, LLC as placement agent in connection with the at-the-market offering by Homology Medicines Inc.
BofA Securities as financial advisor in connection with the PIPE investment of HPX Corp. and its acquisition of Ambipar Emergency Response
Credit Suisse, BofA Securities, SVB Securities and Van Lanschot Kempen as placement agents in connection with the $91 million PIPE investment of European Biotech Acquisition Corp. and its acquisition of Oculis SA
Credit Suisse as sole book-running manager on the upsized initial public offering of SilverBox Corp III, a special purpose acquisition company, of 13,800,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $139.38 million
BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse and Wells Fargo Securities acted as joint book-running managers in connection with the upsized initial public offering of 13,800,000 shares of common stock of Mineralys Therapeutics, Inc. at a public offering price of $16.00 per share, resulting in gross proceeds to the company of $220.8 million
BofA Securities, Piper Sandler, Canaccord Genuity, JMP Securities, a Citizens Company, and Needham & Company as underwriters in connection with the follow-on public offering of 6,500,000 shares of common stock of Paragon 28, Inc. at a public offering price of $17.00 per share, resulting in gross proceeds to the company of approximately $103.4 million
Credit Suisse Securities (USA) LLC, as capital markets advisor, in connection with L Catterton Asia Acquisition Corp.’s proposed business combination with Lotus Technology Inc.
Morgan Stanley as the sole book-running manager in connection with the follow-on public offering of 3,987,914 shares of common stock of Tidewater Inc. at a public offering price of $30.25 per share, resulting in gross proceeds to the company of approximately $120.6 million
Citigroup Global Markets Inc. and Guggenheim Securities, LLC as underwriters in connection with Spring Valley Acquisition Corp. II’s initial public offering of 23,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $230 million
BofA Securities, Stifel and Nicolaus & Company, Incorporated as co-lead placement agents in connection with the private placement offering of 23,045,536 shares of its common stock by Sonendo, Inc. at a purchase price of $0.95 per share, resulting in gross proceeds to the company of approximately $63 million
BofA Securities as the sole placement agent in connection with the private placement offering by 5E Advanced Materials of $60 million aggregate principal amount of its 4.50% secured convertible notes to BEP Special Situations IV
BofA Securities as the sole book-running manager in connection with the follow-on public offering of 2,012,500 shares of common stock of Axonics, Inc. at a public offering price of $63.85 per share, resulting in gross proceeds to the company of approximately $128.5 million
Goldman Sachs & Co. LLC as the sole book-running manager in connection with the follow-on public offering of 1,150,000 shares of common stock of Inspire Medical Systems, Inc. at a public offering price of $215.00 per share, resulting in gross proceeds to the company of approximately $247.2 million
Morgan Stanley as the sole book-running manager in connection with the follow-on public offering of 4,048,000 shares of common stock of Tidewater Inc. at a public offering price of $17.85 per share, resulting in gross proceeds to the company of approximately $72.3 million
BofA Securities, Jefferies, Barclays, Raymond James and LifeSci Capital as joint book-running managers in connection with the follow-on public offering by Tarsus Pharmaceutical Inc. of 5,600,000 shares of its common stock at a public offering price of $13.50 per share, resulting in aggregate gross proceeds to Tarsus Pharmaceutical Inc. of approximately $75.6 million
Morgan Stanley, Baird, Blaylock Van, LLC, Wells Fargo Securities, Janney Montgomery Scott and Ramirez & Co., Inc. as placement agents in connection with the commencement of California Water Service Group’s at-the-market equity program to sell shares of its common stock, having an aggregate offering price of up to $350 million
BofA Securities and Morgan Stanley as joint book-running managers and Wells Fargo Securities, Canaccord Genuity and BTIG as co-managers in connection with the follow-on public offering by Inari Medical, Inc. of 2,000,000 shares of common stock at a public offering price of $81 per share, resulting in gross proceeds to Inari of approximately $162 million
Citigroup Global Markets Inc. as underwriter in connection with Athena Technology Acquisition Corp. II’s initial public offering of 25,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $250 million
BofA Securities, Inc. as underwriter in connection with APx Acquisition Corp. I’s initial public offering of 17,250,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $172.5 million
Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc., Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc. as placement agents in connection with the $154 million PIPE investment of Oaktree Acquisition Corp. II and its related acquisition of Alvotech Lux Holdings S.A.S.
Cowen and Company, LLC as placement agent in connection with the at-the-market offering by Orphazyme A/S
Worldwide Webb Acquisition Corp. in connection with its initial public offering of 23,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $230 million
BofA Securities and Piper Sandler as underwriters in connection with Paragon 28, Inc.’s initial public offering of 8,984,375 shares of common stock at a public offering price of $16.00 per share, resulting in gross proceeds to the company of $144 million
Citigroup Global Markets Inc. as underwriter in connection with Athena Consumer Acquisition Corp.’s initial public offering of 23,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $230 million
BofA Securities, Goldman Sachs & Co. LLC, Piper Sandler and Stifel as book-running managers in connection with Sonendo’s initial public offering of 7,800,000 shares of common stock at a public offering price of $12.00 per share, resulting in gross proceeds to the company of $93.6 million
Evercore ISI as the sole book-running manager on the initial public offering of Learn CW Investment Corp., a special purpose acquisition company, of 23,000,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $230 million
BofA Securities and J.P. Morgan Securities as placement agents on a $300 million PIPE transaction in connection with the de-SPAC combination between TWC Tech Holdings and Cellebrite, a digital intelligence solution company
Morgan Stanley, Goldman Sachs & Co. LLC, Piper Sandler and Cowen as underwriters in connection with Cytek Biosciences, Inc.’s initial public offering of 16,749,330 shares of common stock at a public offering price of $17.00 per share, resulting in gross proceeds to the company of approximately $237 million
BofA Securities, Citigroup and SVB Leerink as underwriters in connection with Caribou Biosciences, Inc.’s initial public offering of 19,000,000 shares of common stock at a public offering price of $16 per share, resulting in gross proceeds to the company of approximately $304 million
BofA Securities, Inc. and Citigroup Global Markets Inc. as co-placement agents on a $2.5 billion PIPE transaction in connection with the de-SPAC combination between SPAC Churchill Capital Corp. IV and Lucid Motors, Inc., an electric car manufacturer
J.P. Morgan, Piper Sandler and William Blair as underwriters in connection with CVRx, Inc.’s offering of 7,000,000 shares of common stock at a public offering price of $18.00 per share, resulting in gross proceeds to the company of approximately $126 million
Credit Suisse, Citigroup, UBS Investment Bank, BTIG, Guggenheim Securities and Macquarie Capital as joint book-running managers on the initial public offering of Elliott Opportunity II, a special purpose acquisition company, of 60,950,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $609.5 million
BofA Securities, Piper Sandler, SVB Leerink, Baird, Guggenheim Securities, Needham & Company and Truist Securities as underwriters in connection with Axonics, Inc.’s offering of 3,500,000 shares of common stock at a public offering price of $50.00 per share, resulting in gross proceeds to the company of approximately $175 million
BofA Securities and Barclays as joint book-running managers on the initial public offering of Valor Latitude Acquisition Corp, a special purpose acquisition company, of 20,000,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $200 million
Citigroup Global Markets Inc. as underwriter on the initial public offering of two, a special purpose acquisition company, of 20,000,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $200 million
Morgan Stanley, Cantor and Guggenheim Securities as underwriters on the initial public offering of Forest Road Acquisition Corp. II, a special purpose acquisition company, of 30,500,000 units at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the company of $350 million
Barclays and BTIG as placement agents in connection with a private investment in 10,000,000 shares of Colonnade Acquisition Corp., a special purpose acquisition company, immediately prior to Colonnade’s acquisition of Ouster, Inc., resulting in gross proceeds to the company of $1.8 billion
J.P. Morgan, Morgan Stanley and BofA Securities as joint book-running managers and H.C. Wainwright & Co. and Kempen & Co. as lead co-managers in connection with the follow-on public offering by Y-mAbs Therapeutics, Inc. of 2,804,878 shares of common stock at a public offering price of $41.00 per share, resulting in aggregate gross proceeds to Y-mAbs of approximately $115 million
Cowen and Intrepid Partners as joint book-running managers in connection with the initial public offering of Flame Acquisition Corp., a special purpose acquisition company, of 28,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $287 million
Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. as underwriters in connection with the initial public offering of SilverBox Engaged Merger Corp I, a special purpose acquisition company, of 34,500,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $345 million
Citigroup Inc. and BofA Securities, Inc. as initial purchasers in connection with the initial public offering of Alpha Capital Acquisition Company, a special purpose acquisition company, of 23,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $230 million
Citigroup as the sole book-running manager in connection with the initial public offering of Arctos NorthStar Acquisition Corp., a special purpose acquisition company, of 31,625,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $316 million
Citigroup and Jefferies as joint book-running managers in connection with the initial public offering of New Vista Acquisition Corp, a special purpose acquisition company, of 27,600,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $276 million
Bank of America Securities as the book-running manager and Oppenheimer & Co. as the co-manager in connection with the follow-on public offering by Protalix BioTherapeutics’ (Protalix) of 8,750,000 shares of common stock at a public offering price of $4.60 per share, resulting in aggregate gross proceeds to Protalix of approximately $40.2 million
BofA Securities and William Blair as joint lead book-running managers and LifeSci Capital as co-manager in connection with Lucira Health, Inc.’s initial public offering of 10,350,000 shares of common stock at a public offering price of $17.00 per share, resulting in gross proceeds to the company of approximately $176 million
Cowen and Company, LLC and Wells Fargo Securities, LLC as book-running managers and Drexel Hamilton, LLC and Siebert Williams Shank & Co., LLC as co-managers in connection with the initial public offering of Spring Valley Acquisition Corp., a special purpose acquisition company, of 23,000,000 units at an offering price of $10.00 per unit, resulting in gross proceeds to the company of $230 million
BofA Securities, Jefferies and Raymond James as joint lead book-running managers and LifeSci Capital and Ladenburg Thalmann as co-managers in connection with Tarsus Pharmaceuticals’ initial public offering of 6,325,000 shares of common stock at a public offering price of $16.00 per share, resulting in gross proceeds to the company of approximately $101.2 million
BofA Securities as sole bookrunning manager in connection with the initial public offering of 5:01 Acquisition Corp., 5AM Ventures’ biotech SPAC, offering 8,000,000 shares of Class A common stock at $10.00 per share, resulting in gross proceeds to the Company of $80 million
BofA Securities and Morgan Stanley as joint lead book-running managers in connection with Pulmonx Corporation’s initial public offering of 11,500,000 shares of common stock at a public offering price of $19.00 per share, resulting in gross proceeds to the Company of approximately $218.5 million
BofA Securities, Cowen and Guggenheim Securities as the joint book-running managers in connection with the global offering of Orphazyme A/S, consisting of 3,966,146 American depositary shares in its initial public offering in the U.S. and 3,650,000 ordinary shares in a European private placement, resulting in gross proceeds to Orphazyme of approximately $83.8 million
BofA Securities, Inc. as sales agent in connection with the commencement of Protalix BioTherapeutics, Inc.’s at-the-market equity program to sell shares of its common stock, having an aggregate offering price of up to $30 million
BofA Securities, Inc., China Renaissance Securities (Hong Kong) Limited, ICBC International Securities Limited and A.G.P./Alliance Global Partners, as joint book-runners, in connection with the SEC-registered follow-on offering of 8,500,001 American Depositary Shares representing 4,250,000.5 Class A ordinary shares of iClick Interactive Asia Group Limited for a total consideration of $72.25 million
BofA Securities, Inc. and Jefferies LLC in connection with the commencement of Lithia Motors, Inc.’s at-the-market equity program to sell shares of its common stock, no par value, having an aggregate offering price of up to $400 million
Cowen, Evercore ISI, Stifel and Mizuho Securities as joint book-running managers in connection with Nkarta, Inc.’s initial public offering of 16,100,000 shares of common stock at a public offering price of $18.00 per share, resulting in gross proceeds to Nkarta of approximately $289.8 million
BofA Securities, Inc., ICBC International Securities Limited and A.G.P./Alliance Global Partners, as placement agents, in connection with the private placement offering by iClick Interactive Asia Group Limited of 2,107,400 Class A ordinary shares for a total consideration of $22 million
BofA Securities and Morgan Stanley as joint book-running managers in connection with Inari Medical, Inc.’s initial public offering of 9,432,949 shares of common stock at a public offering price of $19.00 per share, resulting in gross proceeds to the Company of approximately $179.2 million
Morgan Stanley and BofA Securities as joint book-running managers in connection with the follow-on public offering by MGE Energy of 1,495,000 shares of its common stock at a public offering price of $56.00 per share, resulting in aggregate gross proceeds to MGE Energy of approximately $80,161,900
BofA Securities, Jefferies and William Blair as joint book-running managers and representatives of the underwriters in connection with Lyra Therapeutics, Inc.’s initial public offering of 4,025,000 shares of common stock (including 525,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of $16.00 per share, resulting in gross proceeds to the company of $64.4 million
BofA Securities, J.P. Morgan Securities and Goldman Sachs & Co. LLC as joint book-running managers and representatives of the underwriters in connection with Inspire Medical Systems, Inc.’s offering of 2,300,000 shares common stock (including 300,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of $58.00 per share, resulting in gross proceeds to the company of approximately $133 million
BofA Securities as sole book-running manager in connection with Exact Sciences’ public offering of $1.15 billion aggregate principal amount of its 0.3750% convertible senior notes due 2028, including $150 million in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised over-allotment option
BofA Securities, Citigroup and Credit Suisse as joint book-running managers and representatives of the underwriters in connection with Galera Therapeutics, Inc.’s initial public offering of 5,000,000 million shares of common stock at a public offering price of $12.00 per share, resulting in gross proceeds to Galera of approximately $60 million
Morgan Stanley, JP Morgan and Evercore ISI as representatives of the underwriters in connection with pdvWireless, Inc.’s (dba Anterix) follow-on primary public offering of 2,222,223 shares of common stock at a public offering price of $45.00 per share, resulting in approximately $100 million in gross proceeds to Anterix
Citigroup, Barclays, BofA Securities and Guggenheim Securities, as joint book-running managers and representatives of the underwriters in connection with a follow-on public offering by InterXion Holding N.V. of 4,600,000 ordinary shares at a public offering price of $72.75 per share, resulting in aggregate gross proceeds to InterXion of approximately $321 million
Jefferies LLC as sole book-running manager on the initial public offering of Landcadia Holdings II, Inc. of 31,625,000 units, which includes 4,125,000 units issued pursuant to the exercise by Jefferies of its over-allotment option in full, at an offering price of $10.00 per unit, resulting in approximately $316.25 million in proceeds
Credit Suisse and BofA Securities as joint book-running managers in connection with the $250 million initial public offering of Crescent Acquisition Corp of 25,000,000 units at an offering price of $10.00 per unit, each unit consisting of one share of Class A common stock and one-half of one redeemable warrant
BofA Securities, SVB Leerink and RBC Capital Markets as joint book-running managers and representatives of the underwriters in connection with HOOKIPA Pharma Inc.’s initial public offering of 6,000,000 shares of common stock at a public offering price of $14.00 per share, resulting in gross proceeds to the company of approximately $84 million
BofA Securities and Cowen as joint book-running managers and representatives of the underwriters in connection with Homology Medicines’ follow-on offering, resulting in gross proceeds to the company of approximately $125 million
BofA Securities and the other underwriters in Exact Sciences Corporation’s (i) public offering of $747.5 million aggregate principal amount of its 0.3750% convertible senior notes due 2027, including $97.5 million in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised over-allotment option and (ii) concurrent exchange of approximately $493.4 million of its outstanding principal amount of 1.0% convertible senior notes due 2025 for consideration consisting of an aggregate amount of approximately $493.3 million in cash and an aggregate amount of approximately 2,160,000 shares of the company’s common stock
Cantor Fitzgerald as the sole book-running manager in connection with the follow-on primary public offering of common stock of Globalstar, Inc., resulting in gross proceeds to the company of approximately $60 million
BofA Securities, Leerink Partners and Wells Fargo Securities as joint book-running managers and Guggenheim Securities and Stifel as lead managers in connection with Inspire Medical Systems, Inc.’s follow-on primary and secondary public offering of 2,875,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 375,000 additional shares, at a public offering price of $40.00 per share, resulting in combined gross proceeds to Inspire and the selling stockholders of approximately $115 million
BofA Securities and Morgan Stanley as joint book-running managers and representatives of the underwriters in connection with Axonics Modulation Technologies, Inc.’s initial public offering of 9,200,000 shares of common stock (including 1,200,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of $15.00 per share, resulting in gross proceeds to the company of approximately $138 million
BofA Securities and Cowen and Company, LLC as joint book-running managers and representatives of the underwriters in connection with Y-mAbs Therapeutics, Inc.’s initial public offering of 6,900,000 shares of common stock (including 900,000 shares purchased by the underwriters pursuant to their option to purchase additional shares) at a public offering price of $16.00 per share, resulting in gross proceeds to the Company of approximately $98.3 million
BofA Securities as the sole book-running manager and representative of the underwriters in connection with a follow-on public offering of 6,325,000 shares of Class A common stock of Tilly’s, Inc. (including 825,000 shares purchased by underwriters pursuant to their option to purchase additional shares) sold by certain of its stockholders, including its co-founders Mr. Hezy Shaked and Ms. Tilly Levine
Wells Fargo Securities and Piper Jaffray & Co. as joint book-runners and representatives of the underwriters in connection with Merit Medical Systems, Inc.’s follow-on primary public offering of 4,025,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 525,000 additional shares, at a public offering price of $54.00 per share, resulting in approximately $204.9 million in net proceeds
BofA Securities and Goldman Sachs & Co. LLC as joint book-running managers and representatives of the underwriters in connection with Inspire Medical Systems Inc.’s initial public offering, resulting in gross proceeds to the company of approximately $124.2 million
BofA Securities, Cowen and Evercore ISI as joint book-running managers and representatives of the underwriters in connection with Homology Medicines’ initial public offering, resulting in gross proceeds to the company of approximately $165.6 million
BofA Securities as the sole book-running manager and representative of the underwriters in connection with Exact Sciences Corporation’s public offering of $690 million 1% convertible senior notes due 2025 (including $90 million of notes purchased by the underwriters pursuant to their fully exercised over-allotment option) with an initial conversion price of approximately $75.43 per share of common stock
Morgan Stanley, as representative of the underwriters in connection with Globalstar, Inc.’s follow-on public offering of common stock, resulting in gross proceeds of $119 million
Credit Suisse, as representative of the underwriters in connection with Social Capital Hedosophia Holdings Corp.’s initial public offering, resulting in gross proceeds of $600 million
Citigroup, Goldman Sachs, BofA Securities and JP Morgan as representatives of the underwriters in connection with the initial public offering of Venator Material PLC, a subsidiary of Huntsman Corporation, resulting in gross proceeds of $522.1 million
BofA Securities and Piper Jaffray as representatives of the underwriters in connection with Merit Medical Systems, Inc.’s follow-on primary public offering of 5,175,000 shares of common stock, including the full exercise of the underwriters’ option to purchase 675,000 additional shares, resulting in gross proceeds of $136.5 million
BofA Securities and Piper Jaffray as representatives of the underwriters in connection with the follow-on public offering of 4,059,500 shares of common stock of Entellus Medical, Inc. consisting of 2,883,030 shares sold by Entellus and 1,176,470 shares sold by certain of its stockholders
BofA Securities, Citigroup and Morgan Stanley as representatives of the underwriters in connection with Valvoline Inc.’s initial public offering, resulting in gross proceeds of $759 million
BofA Securities and Piper Jaffray as representatives of the underwriters in connection with the initial public offering of Entellus Medical, Inc. on The Nasdaq Global Market
Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman, Sachs & Co. as representatives of the underwriters in connection with the initial public offering of Zayo Group Holdings, Inc. on the New York Stock Exchange
Goldman, Sachs & Co, Barclays Capital Inc. and Morgan Stanley & Co. LLC as representatives of the underwriters in connection with the follow-on offering of common stock by Zayo Group Holdings, Inc.
Synchronoss Technologies, Inc. in connection with a registered offering of convertible senior notes
Morgan Stanley, J.P. Morgan, Goldman, Sachs & Co. and Deutsche Bank Securities in connection with a $595 million registered secondary offering of common stock by certain selling stockholders of Tribune Media Company
Merrill Lynch & Co. and Goldman, Sachs & Co. as representatives of the underwriters in connection with a common stock and convertible notes offering by Western Refining, Inc.
HeartWare International, Inc. in connection with a follow-on registered public offering of common stock
The underwriters in connection with the initial public offering of Alnylam Pharmaceuticals, Inc. and a follow-on common stock offering
The underwriters in connection with several common stock offerings by Orient-Express Hotels Ltd.
The underwriters in connection with a common stock offering by Sea Containers Ltd.
The underwriters in connection with a common stock offering by McCormick & Schmick’s Seafood Restaurants, Inc
American Axle & Manufacturing Holdings, Inc. (AAM) in connection with its issuance of equity warrants to General Motors Company as part of AAM’s debt restructuring
Lincoln Educational Services Corporation in connection with its initial public offering and several common stock offerings
Stonington Partners Inc. in connection with several registered and unregistered sales of common stock of Lincoln Educational Services Corporation

High-Yield Debt Offerings

Valvoline Inc. on the refinancing of existing debt in connection with the sale of its Global Products business to Aramco for $2.65 billion
Valvoline Inc. on its Rule 144A/Regulation S offering of $535 million senior notes
Valvoline Inc. on its Rule 144A/Regulation S offering of $400 million senior notes
Morgan Stanley & Co. LLC, Barclays Capital Inc., SunTrust Robinson Humphrey, Inc., RBC Capital Markets, LLC, Citigroup Global Markets Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC as joint lead and joint book-running managers in connection with the offering of $800 million senior notes by Zayo Group, LLC and Zayo Capital, Inc.
Citigroup Global Markets Inc., as representative of the initial purchasers, in connection with the offering of $375 million senior notes by Valvoline Finco Two LLC
The initial purchasers in connection with one of the largest leveraged buyouts, which included the issuances of over $11 billion of high yield notes by TXU Corp. (now known as Energy Future Holdings) and its subsidiary Texas Competitive Electric Holdings Company LLC to fund the $45 billion acquisition of TXU Corp. by an investor group led by KKR and TPG
The initial purchasers in connection with various issuances of high yield notes by Cablevision Systems Corporation and its subsidiary CSC Holdings, Inc.
The initial purchasers in connection with several issuances of high yield notes in excess of $1 billion by Zayo Group, LLC
B/E Aerospace, Inc. in connection with its $1.05 billion acquisition of Honeywell’s Consumables Solutions distribution business and the related issuance of $600 million of high yield notes
The initial purchasers in connection with the issuance of $600 million of secured high yield notes by Western Refining, Inc.
The initial purchaser in connection with the issuance of $105 million of high yield notes by Da-Lite Screen Company, Inc.

Investment Grade Debt Offerings

The underwriters in connection with the offering by CBOE Holdings, Inc. of $300 million senior notes.
The underwriters in connection with the issuance of $5 billion of notes by Time Warner Cable Inc.
The underwriters in connection with several issuances in excess of $4 billion of notes by The Boeing Company and Boeing Capital Corporation.
Dr. Pepper Snapple Group, Inc. in connection with its issuance of $1.5 billion of notes.
Boston Scientific Corporation in connection with its issuance of $2 billion of notes.
The underwriters in connection with the issuance of $1.5 billion of notes by Life Technologies Corporation.
The underwriters in connection with the issuance of $500 million of notes by Thomson Reuters Corporation.
The underwriters in connection with the issuance of $500 million of notes by The Lubrizol Corporation.

Tender Offers and Consent Solicitations

Valvoline Inc. in connection with a debt tender offer to repurchase up to $1.0 billion in value of its common stock.
DaimlerChrysler AG in connection with a tender offer, consent solicitation and exchanges of trust securities into debentures in connection with its sale of an 80.1% interest in Chrysler Holding LLC to Cerberus Capital Management, L.P.
The dealer managers in connection with tender offers by Cablevision Systems Corporation and its subsidiary CSC Holdings, Inc.